Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial)
Sponsor: University Hospital Tuebingen
Summary
This trial is a prospective randomized multicenter trial that assigns patients to either a treatment for Acute Respiratory Distress Syndrome (ARDS) with an Extracorporal Membrane Oxygenation (ECMO) immediately after admission to the intensive care unit or conservative treatment. The later can undergo ECMO following failure of conservative therapy as a rescue therapy. Patients will be included within 24 hours of the onset of symptoms of ARDS and will be randomized according to standard procedure. Follow-up will be performed until day 90 after study inclusion.
Official title: Early Versus Late Initiation of ECMO Trial (ELIEO-Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
508
Start Date
2025-03-01
Completion Date
2028-12
Last Updated
2025-05-23
Healthy Volunteers
No
Conditions
Interventions
ECMO
ECMO implantation immediately after ICU admission
Locations (1)
University hospital Tübingen
Tübingen, Germany